![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
King Khaled Eye Specialist Hospital |
---|---|
Information provided by: | King Khaled Eye Specialist Hospital |
ClinicalTrials.gov Identifier: | NCT00238862 |
Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%. Outcome measures will be (1) presence or absence of complete re-epithelialization within 28 days and (2) retention of intact epithelium for at least 90 days.
Condition | Intervention |
---|---|
Corneal Epithelial Defect |
Procedure: Amniotic membrane transplantation Drug: Autologous serum/BSS 20% |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Efficacy of Amniotic Membrane Transplantation and Autologous Serum in Treatment of Persistent Epithelial Defects |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Saudi Arabia | |
King Khaled Eye Specialist Hospital | |
Riyadh, Saudi Arabia, 11462 |
Principal Investigator: | Michael D Wagoner, MD | King Khaled Eye Specialist Hospital |
Study ID Numbers: | RP0511-P |
Study First Received: | October 12, 2005 |
Last Updated: | March 5, 2007 |
ClinicalTrials.gov Identifier: | NCT00238862 History of Changes |
Health Authority: | Saudi Arabia: Ministry of Health; KKESH: IRB Monitor |
Diabetes Corneal transplant Neurotrophic keratitis Post-bacterial keratitis Metaherpetic keratitis |
Diabetes Mellitus Keratitis |